ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2386

Landscape of Immune Cells and Autoimmunity in Systemic Lupus Erythematosus Patients with Obesity

Alexandra Reese1, Chandana Keshavamurthy2, Sneha Centala1, Samantha Ahrens1, Shivani Shah2, Douglas Reeves2, William Davis3, Robert Quinet4, Jerald Zakem1, Qingli Wu1, Kimmy Tran1, Teresa Leeth5, Daniyal Nadeem6, Sarwat Umer7, Samina Hayat5 and Xin Zhang1, 1Ochsner Health, New Orleans, LA, 2Ochsner Clinic Foundation, New Orleans, 3Ochsner Health System, New Orleans, LA, 4Ochsner Health, River Ridge, LA, 5Louisiana State University Shreveport, Shreveport, LA, 6LSU Shreveport, Shreveport, 7LSU HEALTH SHREVEPORT, SHREVEPORT, LA

Meeting: ACR Convergence 2024

Keywords: immunology, Inflammation, obesity, Systemic lupus erythematosus (SLE), T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is an inflammatory autoimmune disease characterized by autoantibodies and disruption of multiple organs due to immunomodulatory dysfunction. Obesity is a prevalent and persistent epidemic that affects more than 31% of the US population. Obesity is well-known as a risk factor for autoimmune disease and considered to cause a chronic inflammatory status. Our recent published studies showed that a high-fat diet exacerbated lupus development and autoimmunity in MRL/lpr lupus-prone mice. Here, we examined the immune cell profiles and the clinical features in non-obese, overweight, and obese lupus patients.

Methods: Blood specimens were collected from 41 consented SLE patients: 10 (24%) non-obese (BMI ≤ 25kg/m2), 8 (20%) overweight (BMI 25-30kg/m2), and 23 (56%) obese (BMI ≥ 30 kg/m2). Multiparameter flow cytometry and serial gating were used to examine immune cell populations in peripheral blood mononuclear cells (PBMCs). Clinical data including demographic information, body mass index (BMI), SLE disease activity (SLEDAI), titers of anti-dsDNA antibody, serum creatinine, urine protein/creatinine ratio, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and complement 3 & 4 (C3, C4) levels were extracted from Epic electronic medical record (EMR) system. Lipid profiles of lupus patients were determined by clinical lab.  Unpaired Student’s t-test and multi-variable ANOVA were used for statistical significance analysis among the groups. Two-tailed p< 0.05 was considered significant.  

Results: SLE patients included in this study were 95% female, 71% African American, 22% Caucasian American, 5% Asian, and 2% Hispanic/Latino. Obese lupus patients had a significantly lower level of high-density lipoprotein (HDL) and higher ratio of total cholesterol/HDL, compared to the non-obese patients and overweight patients. Although there is no difference in anti-dsDNA antibody levels among groups, the percentage of patients with severe lupus (SLEDAI > 6) was significantly higher in the obese (26.3%) and overweight (16.3%) groups than the nonobese group (0%). Flowcytometry results revealed a significantly lower frequency of CD8+ T cells and higher frequency of circulating CD4+ T helper cells (especially CCR4+CCR6- Th2 cells and CD4+ICOS+ T follicular helper cells) in obese and overweight lupus patients, compared to non-obese lupus patients (p< 0.05, p< 0.01). A lower frequency of CXCR3+CCR6- Th1 cells was also found in obese and overweight lupus patients, but there was no difference of Th17 cells among the groups. Clinically, significantly higher levels of urine protein/creatinine ratio (p< 0.05), CRP (p< 0.005), and ESR (p< 0.05) were noted in obese patients compared to non-obese lupus patients.  

Conclusion: Our results showed that obese and overweight lupus patients had an altered Th2/T follicular helper cell dominant immune cell profile and dysfunctional clinical features with worse outcomes. Further study of the association of these immune cells and their cytokines with serologic and clinical outcomes in obese lupus patients may help us understand the complex mechanism underlying the relationship between SLE and obesity. 


Disclosures: A. Reese: None; C. Keshavamurthy: None; S. Centala: None; S. Ahrens: None; S. Shah: None; D. Reeves: None; W. Davis: None; R. Quinet: None; J. Zakem: None; Q. Wu: None; K. Tran: None; T. Leeth: None; D. Nadeem: None; S. Umer: None; S. Hayat: None; X. Zhang: None.

To cite this abstract in AMA style:

Reese A, Keshavamurthy C, Centala S, Ahrens S, Shah S, Reeves D, Davis W, Quinet R, Zakem J, Wu Q, Tran K, Leeth T, Nadeem D, Umer S, Hayat S, Zhang X. Landscape of Immune Cells and Autoimmunity in Systemic Lupus Erythematosus Patients with Obesity [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/landscape-of-immune-cells-and-autoimmunity-in-systemic-lupus-erythematosus-patients-with-obesity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/landscape-of-immune-cells-and-autoimmunity-in-systemic-lupus-erythematosus-patients-with-obesity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology